News
CALZF
0.850
NaN%
--
Positive Report for Polynovo (CALZF) from Morgans
TipRanks · 12/11 22:35
PolyNovo Appoints New Company Secretary and General Counsel
TipRanks · 12/08 02:37
Polynovo (CALZF) Gets a Buy from Canaccord Genuity
TipRanks · 12/08 02:35
PolyNovo Highlights Industry Position at Bell Potter Healthcare Conference
TipRanks · 11/17 23:47
PolyNovo AGM Results: Key Resolutions Passed
TipRanks · 10/28 06:28
PolyNovo Reports Strong Growth and Strategic Expansion
TipRanks · 10/28 04:18
PolyNovo Announces Leadership Change as Chairman Resigns
TipRanks · 10/27 01:07
Macquarie Sticks to Their Buy Rating for Polynovo (CALZF)
TipRanks · 10/20 23:35
Polynovo Limited Appoints New Director to Strengthen Leadership
TipRanks · 10/19 23:57
PolyNovo Appoints Robert Douglas as Non-Executive Director
TipRanks · 10/17 02:48
PolyNovo Appoints Bruce Peatey as CEO to Drive Global Expansion
TipRanks · 10/16 01:47
PolyNovo Appoints Robert Douglas as Non-Executive Director
Barchart · 10/14 19:30
Analysts Offer Insights on Healthcare Companies: Polynovo (OtherCALZF) and Clinuvel Pharmaceuticals (OtherCLVLF)
Barchart · 10/06 23:12
Polynovo Director Increases Stake, Signaling Confidence in Growth
TipRanks · 09/22 00:37
Citigroup Ceases to be Substantial Holder in Polynovo
TipRanks · 09/19 01:28
Polynovo Director Increases Shareholding, Signaling Confidence
TipRanks · 09/15 23:19
Weekly Report: what happened at CALZF last week (0908-0912)?
Weekly Report · 09/15 11:29
Polynovo Director Increases Stake in Company
TipRanks · 09/14 23:29
More
Webull provides a variety of real-time CALZF stock news. You can receive the latest news about Polynovo through multiple platforms. This information may help you make smarter investment decisions.
About CALZF
PolyNovo Limited is an Australia-based medical technology company. The Company’s business includes designing, manufacturing and selling biomedical devices. Its principal activity is the development of medical devices for medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb. NovoSorb is a family of proprietary medical grade polymers that can be utilized to manufacture medical devices designed to support tissue repair. NovoSorb polymer devices can be expressed in a variety of physical formats including foam, coatings, fibers, plastic structures, films, and biologic carriers. Its products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. NovoSorb BTM is a bilayer dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma or burn. NovoSorb MTX has applicability for single stage grafting in burns, chronic, and surgical wounds.